In this issue:
- Outpatient management of cancer-associated PE
- Extended reduced-dose apixaban for cancer associated VTE
- Acute symptomatic PE in patients with upper- vs. lower-extremity DVT
- Acute PE in paediatric patients
- Post-PE phenotypes by invasive cardiopulmonary exercise testing
- Sotatercept for patients with PAH at high risk for death
- Efficacy and safety of sotatercept: pooled PULSAR and STELLAR analysis
- Positioning imatinib for PAH
- Riociguat after balloon pulmonary angioplasty in inoperable CTEPH
- Risk assessment tool for pulmonary endarterectomy
Please login below to download this issue (PDF)